Sustainable Heartland Accelerator Regional Partnership (SHARP) Hub

The Sustainable Heartland Accelerator Regional Partnership Hub (SHARPhub) provides resources and assistance -at no cost – to help turn early-stage life sciences technologies into viable startup companies. SHARPhub collaborates and shares resources and best practices with partners in Kansas, Nebraska, …

The University of Louisville ExCITE (Expediting Commercialization, Innovation, Translation, and Entrepreneurship) REACH Hub

The University of Louisville ExCITE (Expediting Commercialization, Innovation, Translation, and Entrepreneurship) program supports faculty, staff, and students who want to take the ground-breaking, healthcare-related work they do in their labs to the marketplace. UofL ExCITE does this by: Developing infrastructure …

WE-REACH

Mission Leverage public-private partnerships to support end-to-end Innovations for health impact and access Accelerate the transformation of novel discoveries into innovative products Award milestone-driven WE-REACH R&D projects with value-added services Fuel the formation of sustainable start-up companies Train the next …

SBIR/STTR Programs

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are highly competitive programs that encourage domestic small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for commercialization. Through a competitive awards-based program, …

NCATS Rare Diseases Clinical Research Network Funding Information

This webpage lists RDCRN funding sources. The Rare Diseases Clinical Research Network (RDCRN) program advances medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the network, scientists from multiple …

Department of Health and Human Services: RFA-OD-20-016

The NIH calls your attention to a recently published Rapid Acceleration of Diagnostics Radical (RADx-rad) funding opportunity announcement (FOA), RFA-OD-20-016: “RADx-rad Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional).” Specific areas of interest from each …